FRESH-PEF73260-en
A Safety and Pharmacokinetic study in Real-life practice of Pylera® in France: The SAPHARY study
SAPHARY
| Name |
|---|
| France |
The primary objective of the study is to verify the absence of accumulation of bismuth in subjects prescribed Pylera®, a pharmacokinetic approach in a real-life setting.
['Clinical data','Participant-reported health data','Biological data']
Individuals
| Topic | Vocabulary | URI |
|---|---|---|
| Gastroenterology | health theme | |
| cim-11 | http://id.who.int/icd/entity/1987089698 |
{
"level_sex_clusion_I": [
"Male",
"Female"
],
"level_age_clusion_I": [
"Young Adult (19 to 24 years)",
"Adult (25 to 44 years)",
"Middle Aged (45 to 64 years)",
"Aged (65 to 79 years)",
"Aged, 80 and over (80 years and more)"
],
"level_type_clusion_I": [
"Patients population"
],
"level_type_clusion_other": "",
"clusion_I": "",
"clusion_E": ""
}
| Name |
|---|
| Patrick Blin |
| Name | Role |
|---|---|
| UNIVERSITE DE BORDEAUX | sponsor |
| Name |
|---|
| ALLERGAN INDUSTRIE |
| Agency name |
|---|
| CNIL |
| CPP |
| CESREES |
['Through independent healthcare practitioners']
['Other']
Access on specific project only
Observational Study
| Start | End |
|---|---|
| 2014 | 2016 |
Longitudinal or cohort study
| Standard |
|---|
| ['MedDRA coding for neurological and non neurological adverse event (SOC and PT); ATC code'] |
To be defined
The ownership of data is defined in a Master Agreement established between the Sponsor, the University of Bordeaux and ADERA (a non-profit making association).
| Name | |
|---|---|
| Patrick Blin | patrick.blin@u-bordeaux.fr |
FRESH-PEF73260-en